Viewing Study NCT05229003


Ignite Creation Date: 2025-12-24 @ 7:44 PM
Ignite Modification Date: 2025-12-25 @ 5:22 PM
Study NCT ID: NCT05229003
Status: RECRUITING
Last Update Posted: 2024-07-03
First Post: 2022-01-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module